Veradermics, Inc 8-K

What Happened
Veradermics, Inc. announced its financial results for the fourth quarter and the full year ended December 31, 2025 in a press release dated March 30, 2026. The company furnished that press release as Exhibit 99.1 to its Form 8-K (filed March 30, 2026). The report was signed by Reid Waldman, M.D., Chief Executive Officer.

Key Details

• Filing: Current Report on Form 8-K filed March 30, 2026 (Item 2.02: Results of Operations and Financial Condition).
• Period covered: Fourth quarter and year ended December 31, 2025.
• Exhibit: Press release furnished as Exhibit 99.1 to the Form 8-K.
• Signature: Report signed by CEO Reid Waldman, M.D., dated March 30, 2026.

Why It Matters
This 8-K signals that Veradermics has released its latest quarterly and annual earnings information—material data that can affect investor decisions (revenue, profit/loss, cash position, and any management commentary or outlook typically appear in the press release). Retail investors should review the furnished Exhibit 99.1 (the press release) and the company’s full quarterly/annual filings for the detailed financial metrics and any management discussion before making investment decisions.